Scott Gottlieb insider trades
Open-market stock purchases and sales by Scott Gottlieb, Director at Unitedhealth Group Inc, from SEC Form 4 filings since Jan 4, 2010.
Track record: 50% of 8 scored buys are up 5% or more since purchase, averaging +26%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 1, 2026 | UNH Unitedhealth Group Inc | Bought (not open market) | — |
| Sep 22, 2026 | UNH Unitedhealth Group Inc | Bought (not open market) | — |
| Jul 1, 2026 | UNH Unitedhealth Group Inc | Bought (not open market) | — |
| Jun 23, 2026 | UNH Unitedhealth Group Inc | Bought (not open market) | — |
| May 21, 2026 | ILMN Illumina, Inc | Bought (not open market) | $300K |
| May 21, 2026 | TEM Tempus AI, Inc | Bought (not open market) | — |
| Apr 23, 2026 | PFE Pfizer Inc | Bought (not open market) | $205K |
| Apr 1, 2026 | UNH Unitedhealth Group Inc | Bought (not open market) | — |
| Mar 17, 2026 | UNH Unitedhealth Group Inc | Bought (not open market) | — |
| Feb 9, 2026 | ILMN Illumina, Inc | Bought | $23.6K |
| Jan 2, 2026 | UNH Unitedhealth Group Inc | Bought (not open market) | — |
| Nov 3, 2025 | ILMN Illumina, Inc | Bought | $61.1K |
Companies traded
- UNH Unitedhealth Group Inc: other filings, last Oct 1, 2026
- ILMN Illumina, Inc: 2 buys, last May 21, 2026
- TEM Tempus AI, Inc: 9 sales, last May 21, 2026
- PFE Pfizer Inc: 6 buys, last Apr 23, 2026
- CBMX CombiMatrix Corp: 1 buy, last May 9, 2016
- TRGM Targeted Medical Pharma, Inc: other filings, last Jul 22, 2013
- MIPI Molecular Insight Pharmaceuticals, Inc: other filings, last May 13, 2010